Live from ARM's Meeting on the Mesa with Kiji Therapeutics' Dr. Miguel Forte
Cell & Gene: The Podcast
00:00
Advancing Clinical Trials: Targeting GVHD and Beyond
This chapter explores upcoming clinical trials targeting graft-versus-host disease using engineered mesenchymal stem cells. It also highlights the potential for these modified cells to address inflammatory bowel disease and psoriasis, stressing the significance of patient profiling and macrophage modulation in therapy development.
Transcript
Play full episode
